Multi-cancer blood tests are generating excitement because they may help identify cancers before symptoms develop. However, ...

The new blood test detected 90% of early pancreatic cancers, vastly outperforming the standard tumor marker test.

Researchers found hidden amino acid patterns may flag higher relapse risk after surgery.

The Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over ...

Introduction Colorectal cancer (CRC) screening reduces cancer incidence and mortality, but participation rates are suboptimal ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Liquid biopsies look for cancer signals in the blood, and while the tests for early ...

Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...

A noninvasive DNA blood test can identify patients with metastatic castration-resistant prostate cancer (mCRPC) who are most ...

A single preoperative blood sample may help improve the prediction of recurrence or metastasis in patients with colorectal ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield™ blood test for colorectal cancer screening (CRC) is now covered for eligible UnitedHealth Group ...

A single blood test that looks for signs of dozens of cancers sounds revolutionary—but it's important to understand both its ...